Ultralight | $9,300,000 | (Apr 21, 2026)
Sage Haven | $3,000,000 | (Apr 21, 2026)
CREAO AI | $10,000,000 | (Apr 21, 2026)
Nucleus RadioPharma
United States
- Rochester, MN
- 18/10/2023
- Series A
- $56,000,000
Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
- Industry Pharmaceutical Manufacturing
- Website https://nucleusrad.com/
- LinkedIn https://www.linkedin.com/company/nucleus-radiopharma/about/
Related People
Charles ConroyFounder
United States -
Charlotte Metro
Contact: csconroyrph@gmail.com
Skilled negotiator and decision maker with excellent leadership, problem solving and relationship building skills. Expertise includes:
• Specialty Pharmacy
• Pharmacy Operations Management
• Business Development
• Product Development and Launch
• Alliance Management
• Strategic Planning
• Market Planning
• Corporate and Product Strategy
• Team Leadership and Development
• Acquisition Integration
• Operational Improvement
Specialties: Strategic Development, Pharmaceutical Marketing, Medical Device Marketing, Contract Negotiation, Nuclear Medicine, Process Management, New Business Start-up, Acquisitions, Mergers, Divestitures, Six Sigma, Sterile Compounding, Pharmaceutical Compounding, 340B, Supply Chain, Supply Chain Management
Coral | $12,500,000 | (Apr 21, 2026)
Wavelet Medical | $7,000,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
Balerion AI | $6,000,000 | (Apr 17, 2026)
Sepion Technologies | $10,000,000 | (Apr 17, 2026)
Ethermed | $8,500,000 | (Apr 17, 2026)